Annual CFI
$164.63 M
+$1.36 B+113.79%
December 31, 2023
Summary
- As of February 12, 2025, VIR annual cash flow from investing activities is $164.63 million, with the most recent change of +$1.36 billion (+113.79%) on December 31, 2023.
- During the last 3 years, VIR annual CFI has risen by +$174.49 million (+1769.33%).
- VIR annual CFI is now at all-time high.
Performance
VIR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$118.60 M
-$93.00 M-43.95%
September 30, 2024
Summary
- As of February 12, 2025, VIR quarterly cash flow from investing activities is $118.60 million, with the most recent change of -$93.00 million (-43.95%) on September 30, 2024.
- Over the past year, VIR quarterly CFI has dropped by -$93.00 million (-43.95%).
- VIR quarterly CFI is now -48.50% below its all-time high of $230.31 million, reached on June 30, 2023.
Performance
VIR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$253.82 M
+$177.56 M+232.82%
September 30, 2024
Summary
- As of February 12, 2025, VIR TTM cash flow from investing activities is $253.82 million, with the most recent change of +$177.56 million (+232.82%) on September 30, 2024.
- Over the past year, VIR TTM CFI has increased by +$177.56 million (+232.82%).
- VIR TTM CFI is now -14.68% below its all-time high of $297.48 million, reached on September 30, 2021.
Performance
VIR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VIR Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +113.8% | -44.0% | +232.8% |
| 3 y3 years | +1769.3% | +20.9% | +125.6% |
| 5 y5 years | +372.4% | +20.9% | +125.6% |
VIR Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.8% | -48.5% | +117.9% | at high | +117.9% |
| 5 y | 5-year | at high | +113.8% | -48.5% | +117.9% | -14.7% | +117.9% |
| alltime | all time | at high | +113.8% | -48.5% | +117.9% | -14.7% | +117.9% |
Vir Biotechnology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $118.60 M(-44.0%) | $253.82 M(+232.8%) |
| Jun 2024 | - | $211.61 M(+644.6%) | $76.26 M(-19.7%) |
| Mar 2024 | - | $28.42 M(-127.1%) | $94.97 M(-42.3%) |
| Dec 2023 | $164.63 M(-113.8%) | -$104.81 M(+77.8%) | $164.63 M(+41.5%) |
| Sep 2023 | - | -$58.95 M(-125.6%) | $116.31 M(-123.9%) |
| Jun 2023 | - | $230.31 M(+134.8%) | -$487.35 M(-50.8%) |
| Mar 2023 | - | $98.08 M(-164.0%) | -$989.99 M(-17.0%) |
| Dec 2022 | -$1.19 B(+747.5%) | -$153.13 M(-76.9%) | -$1.19 B(-15.8%) |
| Sep 2022 | - | -$662.61 M(+143.3%) | -$1.42 B(+108.1%) |
| Jun 2022 | - | -$272.33 M(+158.4%) | -$681.44 M(+104.2%) |
| Mar 2022 | - | -$105.39 M(-72.1%) | -$333.74 M(+137.0%) |
| Dec 2021 | -$140.81 M | -$377.58 M(-611.2%) | -$140.81 M(-147.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $73.86 M(-2.0%) | $297.48 M(+677.9%) |
| Jun 2021 | - | $75.38 M(-13.9%) | $38.24 M(-244.1%) |
| Mar 2021 | - | $87.53 M(+44.2%) | -$26.55 M(+169.2%) |
| Dec 2020 | -$9.86 M(-96.2%) | $60.71 M(-132.8%) | -$9.86 M(-93.2%) |
| Sep 2020 | - | -$185.38 M(-1851.3%) | -$144.34 M(-263.4%) |
| Jun 2020 | - | $10.59 M(-89.8%) | $88.33 M(-27.7%) |
| Mar 2020 | - | $104.22 M(-241.3%) | $122.22 M(-147.7%) |
| Dec 2019 | -$256.16 M(+323.8%) | -$73.77 M(-256.0%) | -$256.16 M(+40.4%) |
| Sep 2019 | - | $47.29 M(+6.3%) | -$182.39 M(-20.6%) |
| Jun 2019 | - | $44.48 M(-116.2%) | -$229.68 M(-16.2%) |
| Mar 2019 | - | -$274.16 M | -$274.16 M |
| Dec 2018 | -$60.44 M(+101.5%) | - | - |
| Dec 2017 | -$29.99 M | - | - |
FAQ
- What is Vir Biotechnology annual cash flow from investing activities?
- What is the all time high annual CFI for Vir Biotechnology?
- What is Vir Biotechnology annual CFI year-on-year change?
- What is Vir Biotechnology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Vir Biotechnology?
- What is Vir Biotechnology quarterly CFI year-on-year change?
- What is Vir Biotechnology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Vir Biotechnology?
- What is Vir Biotechnology TTM CFI year-on-year change?
What is Vir Biotechnology annual cash flow from investing activities?
The current annual CFI of VIR is $164.63 M
What is the all time high annual CFI for Vir Biotechnology?
Vir Biotechnology all-time high annual cash flow from investing activities is $164.63 M
What is Vir Biotechnology annual CFI year-on-year change?
Over the past year, VIR annual cash flow from investing activities has changed by +$1.36 B (+113.79%)
What is Vir Biotechnology quarterly cash flow from investing activities?
The current quarterly CFI of VIR is $118.60 M
What is the all time high quarterly CFI for Vir Biotechnology?
Vir Biotechnology all-time high quarterly cash flow from investing activities is $230.31 M
What is Vir Biotechnology quarterly CFI year-on-year change?
Over the past year, VIR quarterly cash flow from investing activities has changed by -$93.00 M (-43.95%)
What is Vir Biotechnology TTM cash flow from investing activities?
The current TTM CFI of VIR is $253.82 M
What is the all time high TTM CFI for Vir Biotechnology?
Vir Biotechnology all-time high TTM cash flow from investing activities is $297.48 M
What is Vir Biotechnology TTM CFI year-on-year change?
Over the past year, VIR TTM cash flow from investing activities has changed by +$177.56 M (+232.82%)